View Older Stories View More Recent Stories
-
Wedbush Morgan Reiterates an 'Outperform' on Comverse Tech (CMVT); Adjusts PT & Estimates
-
Unusual 11 Mid-Day Movers 10/05: ROIAK, DEPO, AVII, CMLS Higher; FOLD, SGEN, SCLN, REED Lower
-
Notable Analyst Rating Changes 10/05: WFC, COP, GD, RIMM, BBT, UCTT Upgraded; AMD, VLO, AMAG, PAY Downgraded
-
Wedbush Morgan Downgrades Investment Technology Group (ITG) to Neutral
-
Wedbush Morgan Downgrades Amicus Therapeutics (FOLD) to Underperform; Slashes PT
-
Wedbush Morgan Downgrades VeriFone (PAY) to Underperform; Lowers 2010 Estimates
-
Wedbush Morgan Initiates Coverage on Lime Energy (LIME) with an Outperform
-
Wedbush Morgan Raises First Solar (FSLR) Price Target to $170; Reiterates 'Outperform'
-
Wedbush Raises Price Target on Cisco (CSCO) to $25, Maintains Neutral
-
Wedbush Morgan Upgrades ViaSat (VSAT) to Outperform; WildBlue Deal Attractive on Price & Synergy
-
Wedbush Morgan Reiterates an 'Outperform' on ON Semiconductor (ONNN); Raises PT
-
Wedbush Morgan Maintains an 'Outperform' on CEVA (CEVA); Raises Price Target
-
Wedbush Morgan Upgrades National CineMedia (NCMI) to Neutral
-
Wedbush Morgan Maintains an 'Underperform' Rating on Garmin Ltd. (GRMN); Nüvifone Sales to Fall Short of Expectations
-
Wedbush Morgan Maintains an 'Underperform' on AMCOL International (ACO); Adjusts Estimates & Price Target
-
Wedbush Morgan Maintains a 'Neutral' on Zumiez (ZUMZ); Raises Estimates & Price Target
-
Wedbush Morgan Maintains an 'Outperform' on Micron Technology (MU); Raises Q4 and FY10 Estimates
-
Wedbush Morgan Reiterates an 'Outperform' on Finish Line (FINL); Raises Price Target
-
Wedbush Morgan Maintains an Outperform on Chelsea Therapeutics (CHTP); Attractive Valuation
-
Wedbush Morgan Reiterates an 'Outperform' on Maxwell Technologies (MXWL); Raises PT
-
Wedbush Morgan Reiterates an 'Outperform' rating on McDonald's (MCD); Best Ideas List
-
Wedbush Morgan Reiterates a 'Neutral' on Jack in the Box (JACK); Adjusting Estimates, Lowers PT
-
Wedbush Morgan Says Takeover Rumors on BioMarin (BMRN) Are Premature; 2010 Value-Drivers Have Potential Upside
-
Wedbush Morgan Reiterates an 'Outperform' on Bed Bath & Beyond (BBBY); Raises Estimates & PT Slightly
-
Wedbush Lifts Target on Polycom (PLCM) to $28; Maintains Outperform
-
Wedbush Morgan Reiterates an 'Outperform' on Carnival (CCL); Adjusts 2009-10 Estimates
-
Wedbush Morgan Upgrades Salix Pharmaceuticals (SLXP) to Outperform
-
Wedbush Morgan Downgrades Inspire Pharmaceuticals (ISPH) to Neutral
-
Wedbush Morgan Initiates Coverage on Stericycle (SRCL) with a Neutral
-
Wedbush Morgan Initiates Coverage on Perma-Fix Environmental Services (PESI) with a Neutral
-
Wedbush Morgan Removes Gymboree (GYMB) from the 'Best Ideas List' After Recent Share Outperformance
-
Wedbush Morgan Maintains a 'Neutral' SunPower (SPWRA); Adjusts Estimates & Price Target
-
Analyst Raises Target on Wynn (WYNN) to $57, Las Vegas Sands (LVS) to $10; Says Valuations Rich
-
STEC (STEC) Higher After Defended By Analyst
-
Wedbush Morgan Reiterates an 'Underperform' on Sonic Corp. (SONC); Adjusts Estimates & Price Target
-
Wedbush Morgan Maintains an 'Outperform' on Nektar Therapeutics (NKTR); Raises Price Target
-
Wedbush Morgan Maintains an 'Outperform' on Cytokinetics (CYTK); Raises PT
-
Wedbush Morgan Maintains a 'Neutral' on Ceragon Networks Ltd. (CRNT); Raises Price Target
-
Wedbush Morgan Downgrades Take-Two Interactive Software (TTWO) to Neutral; Valuation Call
-
Wedbush Morgan Upgrades Zumiez (ZUMZ) to Neutral
-
Wedbush Morgan Upgrades Tempur-Pedic International (TPX) to Outperform; Innovative New Products, Improved Retail Selling Strategy
-
Wedbush Morgan Upgrades Callaway Golf (ELY) to Outperform; Expected Market Share Gains in 2010
-
Wedbush Morgan Reiterates a 'Buy' on Bed Bath & Beyond (BBBY); Expect Another Beat For Q2
-
STEC (STEC) Whacked On Competition Fears
-
Wedbush Raises Kopin (KOPN) Price Target to $5; Maintains Outperform
-
Wedbush Morgan Maintains a 'Neutral' on Kenexa Corp (KNXA); Raises Price Target
-
Wedbush Morgan Downgrades Ceragon Networks Ltd. (CRNT) to Neutral
-
Wedbush Morgan Reiterates a 'Buy' Rating on ImmunoGen (IMGN); Positive Surprise From License Agreement
-
Wedbush Morgan Initiates Coverage on Primoris Services (PRIM) with a Buy; Competititive Advantages
-
Omniture (OMTR) Downgraded at BMO Capital; Upgraded at Wedbush Morgan
